3
Announcements
Trials
Browse
Landscape
Status
Completed
66
Active not recruiting
35
Recruiting
33
Terminated
32
Unknown
16
Withdrawn
10
Not yet recruiting
7
Suspended
1
No longer available
1
Approved for marketing
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
1
Interventions
elotuzumab
4
Lenalidomide
3
Dexamethasone
3
Bortezomib
3
Panobinostat
2
ulocuplumab
1
talquetamab
1
selinexor
1
pomalidomide
1
plerixafor
1
fludarabine phosphate
1
carfilzomib
1
Whole-Body Irradiation
1
Tacrolimus
1
Prednisone
1
Mycophenolic Acid
1
Melphalan
1
Cytarabine
1
Cord Blood Stem Cell Transplantation
1
Calcium Dobesilate
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Multiple Myeloma
×
pomalidomide
×
Clear all
NCT03723096
2018-12-20
Expanded Access for CC-4047
Celgene
No longer available